CDMRP: Bone Marrow Failure Research Program (BMFRP)

Below is a brief summary. Please check the full solicitation before applying (link in resources section).

Executive Summary:

The FY26 Bone Marrow Failure Research Program (BMFRP) pre-announcement is live. This is an early signal to start preparing now—formal funding opportunities will follow on Grants.gov. There is no application deadline specified in this pre-announcement, and investigators should not wait for the full announcement to begin planning.

This program will fund research addressing bone marrow failure (BMF), with a focus on treatments, disease understanding, and community resources. Pre-announcements like this are your only early advantage—teams that move now are significantly more competitive once the FOA drops.

How much funding would I receive?

Funding varies by award mechanism:

  • Idea Development Award

    • Maximum: $800,000 total costs

    • Period of performance: Up to 3 years

  • Investigator-Initiated Research Award

    • Maximum: $1,250,000 total costs

    • Period of performance: Up to 3 years

  • Resource Development Award

    • Maximum: $1,250,000 total costs

    • Period of performance: Up to 2 years

Total costs include direct and indirect costs.

What could I use the funding for?

Projects must align to at least one required FY26 BMFRP focus area:

  • Develop durable resources for the bone marrow failure research community

  • Find effective BMF treatments and cures

  • Understand the causes and progression of BMF diseases

Each award mechanism has specific intent:

  • Idea Development Award: Early-stage, hypothesis-driven research with translational potential

  • Investigator-Initiated Research Award: More mature research building on prior findings with strong preliminary data

  • Resource Development Award: Creation of shared tools, datasets, or infrastructure for the BMF community

Are there any additional benefits I would receive?

  • Partnering Principal Investigator option available under the Investigator-Initiated Research Award

  • Separate review tracks for early-career vs. established investigators (Idea Development Award)

  • Encouragement for correlative studies tied to existing clinical trials/studies

  • Emphasis on translational potential, including work supporting an Investigational New Drug (IND) application

What is the timeline to apply and when would I receive funding?

  • Pre-announcement released: March 10, 2026

  • Pre-application required via eBRAP before full application

  • Full applications are invitation-only after preproposal review

  • Funding opportunity announcements will be posted on Grants.gov

  • Application deadline: Not specified in the pre-announcement

  • Award timing: Not specified in the pre-announcement

Where does this funding come from?

  • FY26 Defense Appropriations Act

  • Managed by the Congressionally Directed Medical Research Programs (CDMRP)

  • Under the Defense Health Agency Research and Development – Medical Research and Development Command (DHA R&D-MRDC)

Who is eligible to apply?

Eligibility depends on the award mechanism:

  • Idea Development Award:

    • Early-Career Investigators (<10 years from first appointment)

    • Established Investigators (≥10 years from first appointment)

  • Investigator-Initiated Research Award:

    • Independent investigators at all career levels

  • Resource Development Award:

    • Independent investigators at all career levels

Additional institutional or organizational eligibility is not specified in the pre-announcement.

What companies and projects are likely to win?

Based on required criteria:

  • Projects must align tightly with one of the FY26 BMFRP focus areas

  • Strong scientific rationale and testable hypothesis (Idea Development Award)

  • Preliminary data required (Investigator-Initiated and Resource Development Awards)

  • Clear translational impact and potential to advance patient care

  • Resource proposals must demonstrate data/sample access and a clear distribution plan

Are there any restrictions I should know about?

  • Preproposal required; full applications are invitation-only

  • Clinical trials are not allowed under any mechanism

  • Applications must align to specified focus areas

  • Resource Development Award is limited to the resource-focused track only

  • The pre-announcement does not obligate the government to fund awards

How long will it take me to prepare an application?

The structure implies:

  • Initial preproposal preparation (required for all mechanisms)

  • Full proposal only if invited

The pre-announcement is explicitly intended to give teams time to begin planning ahead of the formal deadlines.

How can BW&CO help?

BW&CO supports companies pursuing defense innovation and CSO opportunities like this one.

We help by:

  • Position your project against the three distinct award mechanisms

  • Build a preproposal strategy that secures invitation to full application

  • Shape your narrative around CDMRP review expectations and translational impact

  • Align your work to IND-enabling or high-impact outcomes where applicable

How much would BW&CO Charge?

We have both fractional engagements ($250 an hour) and full engagements ($13,000 + 5%) available.

Additional Resources

Review the solicitation here.

Previous
Previous

CDMRP: Joint Warfighter Medical Research Program (JWMRP)

Next
Next

ERDC: Geospatial Research Laboratory - Commercial Solutions Openings (CSO)